Cart
sales@molnova.com
[4-(4-phenylpiperazin-1-yl)oxan-4-yl]methanamine
CAS No. 1157013-41-6
[4-(4-phenylpiperazin-1-yl)oxan-4-yl]methanamine( —— )
Catalog No. M28426 CAS No. 1157013-41-6
[4-(4-phenylpiperazin-1-yl)oxan-4-yl]methanamine is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 101 | Get Quote |
|
| 5MG | 155 | Get Quote |
|
| 10MG | 232 | Get Quote |
|
| 25MG | 397 | Get Quote |
|
| 50MG | 584 | Get Quote |
|
| 100MG | 833 | Get Quote |
|
| 500MG | 1683 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name[4-(4-phenylpiperazin-1-yl)oxan-4-yl]methanamine
-
NoteResearch use only, not for human use.
-
Brief Description[4-(4-phenylpiperazin-1-yl)oxan-4-yl]methanamine is a chemical compound.
-
Description[4-(4-phenylpiperazin-1-yl)oxan-4-yl]methanamine is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1157013-41-6
-
Formula Weight275.396
-
Molecular FormulaC16H25N3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNCC1(CCOCC1)N1CCN(CC1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shipkova M, Niedmann PD, Armstrong VW, Schütz E, Wieland E, Shaw LM, Oellerich M. Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure. Clin Chem. 1998 Jul;44(7):1481-8. PMID: 9665427.
molnova catalog
related products
-
RO5203648 HCl
RO5203648 HCl is a partial agonist of trace amine-related receptor 1 (TAAR1) with antipsychotic and antidepressant-like activities. RO5203648 HCl can be used in studies about neuropsychiatric therapeutics.
-
Eprodisate disodium
Eprodisate Disodium is the orally available disodium salt form of Eprodisate, a negatively charged sulfonated inhibitor of fibrillogenesis, that can be used in the treatment of amyloid A (AA) amyloidosis.
-
D-D-D-D-D
D-D-D-D-D
